European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)-Reference-Cited by-同舟云学术

European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)

Published:2020-06-29 Issue:1 Volume:15 Page:
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet J Rare Dis

Author:

Eker Omer F.,Boccardi Edoardo,Sure Ulrich,Patel Maneesh C.,Alicante Saverio,Alsafi Ali,Coote Nicola,Droege Freya,Dupuis Olivier,Fialla Annette Dam,Jones Bryony,Kariholu Ujwal,Kjeldsen Anette D.,Lefroy David,Lenato Gennaro M.,Mager Hans Jurgen,Manfredi Guido,Nielsen Troels H.,Pagella Fabio,Post Marco C.,Rennie Catherine,Sabbà Carlo,Suppressa Patrizia,Toerring Pernille M.,Ugolini Sara,Buscarini Elisabetta,Dupuis-Girod Sophie,Shovlin Claire L.

Funder

European Commission

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics(clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13023-020-01386-9.pdf

Reference46 articles.

1. Hereditary haemorrhagic telangiectasia, available at www.orpha.net/consor/www/cgi-bin/OC_Exp.php?lng=EN&Expert=774 (accessed 10th Feb 2020).

2. Bideau A, Plauchu H, Brunet G, Robert J. Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence. Population. 1989;44:3–22.

3. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med. 1999;245:31–9.